Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common stock, par value $ 0.000001 per share
-
Shares outstanding
-
6,505,400
-
Total 13F shares
-
3,338,959
-
Share change
-
-438,975
-
Total reported value
-
$63,741,277
-
Price per share
-
$19.09
-
Number of holders
-
38
-
Value change
-
-$66,077,021
-
Number of buys
-
24
-
Number of sells
-
21
Institutional Holders of Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) as of Q4 2024
As of 31 Dec 2024,
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,338,959 shares.
The largest 10 holders included
Vivo Capital, LLC, CPMG Inc, BML Capital Management, LLC, Boxer Capital Management, LLC, Siren, L.L.C., VANGUARD GROUP INC, SUPERSTRING CAPITAL MANAGEMENT LP, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, and ORBIMED ADVISORS LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.